Search

Copyright of Progress in Modern Biomedicine is the property of Publishing House of Progress in Modern Biomedicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective: To introduce and evaluate a new clinical grouping and therapeutic schedule of heel pain caused by calcaneal spurs and plantar fasciitis. Methods: 45 patients (60 feet) who were admitted in our hospital from 2013.01 to 2015.01 and diagnosed as heel pain caused by calcaneal spurs and plantar fasciitis were admitted in our experiment. Results: 1)The relationship between the symptom, function and the new clinical grouping and the relationship between substance p and the new clinical grouping were expored. 2) 45 patients were brought into 3 groups randomly: A: spurs excision; B: substance p inhibition; C:(both). Clinical outcomes were evaluated by visual analogue scale (VAS) and the American Orthopedic Foot and Ankle Society (AOFAS) ankle-hindfoot scores. 1) There were significant difference in the VAS and AOFAS between the I patients and the II patients. However, no difference were found in the spur index. 2) There were significant difference in the substance p, VAS and the clinical grouping. 3) All patients were improved after the therapy in all 3 groups and the group C was significantly better than other groups. No other complication was shown. The new clinical grouping has significant advantage in diagnosis and therapy. Conclusion: The new therapy methord of spurs excision and substance p inhibition has notable dominance than the normal methord, which could be a new and effectivly better way to cure heel pain. [ABSTRACT FROM AUTHOR]

OBJECTIVE: To probe into the clinical efficacy of cocktail neuroprotective agents(N6) in treatment of spasm in patient with traumatic spinal cord injury (TSCI). METHODS: 189 patients with TSCI diagnosed by Jinan Military General Hospital from Jan.2013 to Jun.2016 were retrospectively selected and divided into observation group (102 cases) and control group(87 cases) according to the application of cocktail neuroprotective agents(N6). The incidence of spasm of two groups were observed and compared at 2 months and 12 months after injured;for patients stricken by spasm at 2 months after injured, the total effective rate at 12 months after injured were observed and compared. RESULTS: At 2 months and 12 months after injured, the incidence of spasm of the observation group was significantly lower than that of the control group, with statistically significant difference (P ＜ 0.05). 12 months after injured,the total effective rate of the observation group (62.79％, 27/43) was significantly higher than that of the control group(35.85％, 19/53), with statistically significant difference(P ＜0.05). CONCLUSIONS: The cocktail neuroprotective agents(N6) can effectively reduce the incidence of spasm in patient with TSCI, with high cure rate. [ABSTRACT FROM AUTHOR]